Assessment of Surgically Removed Abdominal Wall Endometriomas

Clinico-pathological Assessment of Surgically Removed Abdominal Wall Endometriomas

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04639063

Enrollment

Registered

2020-11-20

Start date

2020-10-17

Completion date

2020-12-20

Last updated

2021-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis Outside Pelvis

Brief summary

A retrospective review of all patients who underwent surgery for an anterior abdominal wall mass which confirmed by pathology examination as an endometrioma will be completely performed. The clinical data will be recorded and pathology report diagnosis will be correlated with the clinical data to assess the possible causes of endometrioma in the women treated in our tertiary hospital and the efficacy of the surgical excision.

Detailed description

Our hospital is a tertiary center for performing Cesarean sections, external endometriosis (Endometrioma) is a challenging complication for this operation, many treatment choices are available and the most common is the surgical excision, however recurrence could be seen after the surgical operation. We assess all patients who underwent surgical excision for abdominal wall endometriomas in our hospital by retrieving the medical files and pathology reports to study the possible age group,causes and duration of endometriomas. Also the rate of enodmetriomas among the previously experienced females with cesarean section operations. Pathological diagnosis tools will be also assessed. Ethical approval was obtained from the local committee. Results will be statistically assessed using SPSS programm.

Interventions

OTHERMicroscopic examination using H&E stained slides

Reexamination of the stained slides of the patients from the hospital archive and adding a CD10 stain when required

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

15 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Female * Surgically removed abdominal wall endometrioma

Exclusion criteria

* Male (very very rare to occur) * medically treated enodmetrioma * Outside treated patients

Design outcomes

Primary

Measure	Time frame	Description
Positive for endometrioma	1 day	Presence of endometrial glands and stroma along with hemosidren pigment under microscopic examination, confirms the diagnosis and the case will be calculated and the related clinical data

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026